Logo image of NVJP.DE

UMICORE (NVJP.DE) Stock Fundamental Analysis

Europe - FRA:NVJP - BE0974320526 - Common Stock

17.07 EUR
+0.27 (+1.61%)
Last: 10/23/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, NVJP scores 4 out of 10 in our fundamental rating. NVJP was compared to 66 industry peers in the Chemicals industry. While NVJP is still in line with the averages on profitability rating, there are concerns on its financial health. NVJP has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NVJP was profitable.
NVJP had a positive operating cash flow in the past year.
Of the past 5 years NVJP 4 years were profitable.
In the past 5 years NVJP always reported a positive cash flow from operatings.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

NVJP has a Return On Assets (1.50%) which is comparable to the rest of the industry.
NVJP's Return On Equity of 6.30% is fine compared to the rest of the industry. NVJP outperforms 60.61% of its industry peers.
With a decent Return On Invested Capital value of 6.40%, NVJP is doing good in the industry, outperforming 69.70% of the companies in the same industry.
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROIC 6.4%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

NVJP has a Profit Margin (0.80%) which is comparable to the rest of the industry.
NVJP has a Operating Margin of 2.57%. This is comparable to the rest of the industry: NVJP outperforms 45.45% of its industry peers.
Looking at the Gross Margin, with a value of 7.76%, NVJP is doing worse than 83.33% of the companies in the same industry.
NVJP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NVJP is still creating some value.
NVJP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for NVJP remains at a similar level compared to 5 years ago.
Compared to 1 year ago, NVJP has a worse debt to assets ratio.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NVJP has an Altman-Z score of 2.80. This is not the best score and indicates that NVJP is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of NVJP (2.80) is better than 66.67% of its industry peers.
NVJP has a debt to FCF ratio of 50.79. This is a negative value and a sign of low solvency as NVJP would need 50.79 years to pay back of all of its debts.
The Debt to FCF ratio of NVJP (50.79) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.10 is on the high side and indicates that NVJP has dependencies on debt financing.
The Debt to Equity ratio of NVJP (1.10) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Altman-Z 2.8
ROIC/WACC1.04
WACC6.16%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

NVJP has a Current Ratio of 1.37. This is a normal value and indicates that NVJP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NVJP (1.37) is worse than 69.70% of its industry peers.
NVJP has a Quick Ratio of 1.37. This is a bad value and indicates that NVJP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NVJP (0.72) is worse than 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.72
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

NVJP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.12%.
NVJP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.85% yearly.
NVJP shows a small growth in Revenue. In the last year, the Revenue has grown by 2.55%.
Measured over the past years, NVJP shows a decrease in Revenue. The Revenue has been decreasing by -3.21% on average per year.
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%

3.2 Future

Based on estimates for the next years, NVJP will show a small growth in Earnings Per Share. The EPS will grow by 7.13% on average per year.
Based on estimates for the next years, NVJP will show a small growth in Revenue. The Revenue will grow by 1.36% on average per year.
EPS Next Y19.15%
EPS Next 2Y12.31%
EPS Next 3Y10.33%
EPS Next 5Y7.13%
Revenue Next Year-2.58%
Revenue Next 2Y2.11%
Revenue Next 3Y1.65%
Revenue Next 5Y1.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.11, NVJP is valued correctly.
72.73% of the companies in the same industry are more expensive than NVJP, based on the Price/Earnings ratio.
NVJP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.83.
The Price/Forward Earnings ratio is 12.77, which indicates a correct valuation of NVJP.
75.76% of the companies in the same industry are more expensive than NVJP, based on the Price/Forward Earnings ratio.
NVJP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.82.
Industry RankSector Rank
PE 15.11
Fwd PE 12.77
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

NVJP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NVJP is cheaper than 65.15% of the companies in the same industry.
NVJP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 74.56
EV/EBITDA 8.53
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

NVJP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y12.31%
EPS Next 3Y10.33%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.05%, NVJP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.14, NVJP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, NVJP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

The dividend of NVJP has a limited annual growth rate of 0.67%.
Dividend Growth(5Y)0.67%
Div Incr Years0
Div Non Decr Years4
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

93.29% of the earnings are spent on dividend by NVJP. This is not a sustainable payout ratio.
NVJP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP93.29%
EPS Next 2Y12.31%
EPS Next 3Y10.33%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
NVJP.DE Dividend Payout.NVJP.DE Dividend Payout, showing the Payout Ratio.NVJP.DE Dividend Payout.PayoutRetained Earnings

UMICORE

FRA:NVJP (10/23/2025, 7:00:00 PM)

17.07

+0.27 (+1.61%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners35.32%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.21B
Revenue(TTM)16.10B
Net Income(TTM)128.82M
Analysts66.67
Price Target14.26 (-16.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly Dividend0.8
Dividend Growth(5Y)0.67%
DP93.29%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.15%
PT rev (3m)6.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.46%
EPS NY rev (3m)23.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)2.89%
Valuation
Industry RankSector Rank
PE 15.11
Fwd PE 12.77
P/S 0.26
P/FCF 74.56
P/OCF 8.95
P/B 2.06
P/tB 2.53
EV/EBITDA 8.53
EPS(TTM)1.13
EY6.62%
EPS(NY)1.34
Fwd EY7.83%
FCF(TTM)0.23
FCFY1.34%
OCF(TTM)1.91
OCFY11.17%
SpS65.35
BVpS8.29
TBVpS6.75
PEG (NY)0.79
PEG (5Y)N/A
Graham Number14.52
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROCE 8.18%
ROIC 6.4%
ROICexc 8.19%
ROICexgc 9.07%
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
FCFM 0.35%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
F-Score5
Asset Turnover1.87
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Debt/EBITDA 3.22
Cap/Depr 144.97%
Cap/Sales 2.57%
Interest Coverage 4.12
Cash Conversion 67.19%
Profit Quality 43.79%
Current Ratio 1.37
Quick Ratio 0.72
Altman-Z 2.8
F-Score5
WACC6.16%
ROIC/WACC1.04
Cap/Depr(3y)224.12%
Cap/Depr(5y)196.78%
Cap/Sales(3y)3.57%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
EPS Next Y19.15%
EPS Next 2Y12.31%
EPS Next 3Y10.33%
EPS Next 5Y7.13%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%
Revenue Next Year-2.58%
Revenue Next 2Y2.11%
Revenue Next 3Y1.65%
Revenue Next 5Y1.36%
EBIT growth 1Y136.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.86%
EBIT Next 3Y23.57%
EBIT Next 5Y16.17%
FCF growth 1Y136.84%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-3.36%
OCF growth 3Y-11.62%
OCF growth 5Y12.64%

UMICORE / NVJP.DE FAQ

What is the ChartMill fundamental rating of UMICORE (NVJP.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NVJP.DE.


What is the valuation status for NVJP stock?

ChartMill assigns a valuation rating of 5 / 10 to UMICORE (NVJP.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for UMICORE?

UMICORE (NVJP.DE) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for NVJP stock?

The Price/Earnings (PE) ratio for UMICORE (NVJP.DE) is 15.11 and the Price/Book (PB) ratio is 2.06.


What is the financial health of UMICORE (NVJP.DE) stock?

The financial health rating of UMICORE (NVJP.DE) is 3 / 10.